Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.
By the end of 2010, Latin America and the Caribbean (LAC) achieved 63% antiretroviral treatment (ART) coverage. Measures to control HIV drug resistance (HIVDR) at the country level are recommended to maximize the efficacy and sustainability of ART programs. Since 2006, the Pan American Health Organi...
| Publicado en: | Pan American Journal of Public Health Vol. 30; no. 6; pp. 657 - 663 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artículo |
| Publicado: |
World Health Organization
Dec2011
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=71407686&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 71407686 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 10204989 55OA jtl: Pan American Journal of Public Health issn: 10204989 maglogo: N pubinfo: dt: Dec2011 vid: 30 iid: 6 pid: 437 pub: World Health Organization artinfo: ui: 71407686 10.1590/S1020-49892011001200026 ppf: 657 ppct: 6 formats: fmt: @attributes: type: P size: 129KB tig: atl: Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean. aug: au: Ravasi, Giovanni Jack, Noreen Alonso Gonzalez, Mónica Sued, Omar Pérez-Rosales, María Dolores Gomez, Bertha Vila, Marcelo Del Riego, Amalia Ghidinelli, Massimo affil: Pan American Health Organization, Brasilia, Brazil Pan American Health Organization, HIV Caribbean Office, Port of Spain, Trinidad and Tobago Pan American Health Organization, Washington, DC, United States of America Pan American Health Organization, San Salvador, El Salvador Pan American Health Organization, Bogotá, Colombia Pan American Health Organization, Buenos Aires, Argentina su: Latin America Caribbean Epidemics Antiretroviral agents Drug resistance sug: subj: Epidemics Latin America Caribbean Antiretroviral agents Drug resistance keyword: Caribbean region drug resistance epidemiologic surveillance HIV regional strategies world strategies América Latina estrategias mundiales estrategias regionales región del Caribe resistencia a medicamentos vigilancia epidemiológica VIH Caribbean region drug resistance epidemiologic surveillance HIV regional strategies world strategies América Latina estrategias mundiales estrategias regionales región del Caribe resistencia a medicamentos vigilancia epidemiológica VIH ab: By the end of 2010, Latin America and the Caribbean (LAC) achieved 63% antiretroviral treatment (ART) coverage. Measures to control HIV drug resistance (HIVDR) at the country level are recommended to maximize the efficacy and sustainability of ART programs. Since 2006, the Pan American Health Organization has supported implementation of the World Health Organization (WHO) strategy for HIVDR prevention and assessment through regional capacity-building activities and direct technical cooperation in 30 LAC countries. By 2010, 85 sites in 19 countries reported early warning indicators, providing information about the extent of potential drivers of drug resistance at the ART site. In 2009, 41.9% of sites did not achieve the WHO target of 100% appropriate first-line prescriptions; 6.3% still experienced high rates (> 20%) of loss to follow-up, and 16.2% had low retention of patients (< 70%) on first-line prescriptions in the first year of treatment. Stock-outs of antiretroviral drugs occurred at 22.7% of sites. Haiti, Guyana, and the Mesoamerican region are planning and implementing WHO HIVDR monitoring surveys or threshold surveys. New HIVDR surveillance tools for concentrated epidemics would promote further scale-up. Extending the WHO HIVDR lab network in Latin America is key to strengthening regional lab capacity to support quality assured HIVDR surveillance. The WHO HIVDR control strategy is feasible and can be rolled out in LAC. Integrating HIVDR activities in national HIV care and treatment plans is key to ensuring the sustainability of this strategy. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|